Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)

Am J Cardiol. 2002 Jun 1;89(11):1308-10. doi: 10.1016/s0002-9149(02)02334-2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acarbose / adverse effects
  • Adverse Drug Reaction Reporting Systems
  • Anticholesteremic Agents / adverse effects
  • Atorvastatin
  • Chromans / adverse effects*
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • Heptanoic Acids / adverse effects*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hypoglycemic Agents / adverse effects*
  • Insulin / adverse effects
  • Male
  • Metformin / adverse effects
  • Middle Aged
  • Pyrroles / adverse effects*
  • Simvastatin / adverse effects
  • Sulfonylurea Compounds / adverse effects
  • Thiazoles / adverse effects*
  • Thiazolidinediones*
  • Troglitazone

Substances

  • Anticholesteremic Agents
  • Chromans
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents
  • Insulin
  • Pyrroles
  • Sulfonylurea Compounds
  • Thiazoles
  • Thiazolidinediones
  • Metformin
  • Atorvastatin
  • 2,4-thiazolidinedione
  • Simvastatin
  • Troglitazone
  • Acarbose